PEN Penumbra Inc

USD 298.25 +19.48 ( +6.99%)
Icon

Penumbra Inc (PEN) Financial Statements

COMMON STOCK | Medical Devices | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 298.25

+19.48 (+6.99%)

USD 10.73B

1.57M

USD 287.61(-3.57%)

USD 249.83 (-16.23%)

Icon

PEN

Penumbra Inc (USD)
COMMON STOCK | NYE
USD 298.25
+19.48 ( +6.99%)

Penumbra Inc (PEN) Annual Income Statement (USD)

PEN Quarterly Financials (USD)

Frequently Asked Questions About Penumbra Inc (PEN) Stock

Penumbra Inc's (PEN) last reported annual revenue was USD 1.19 Billion.

Penumbra Inc's (PEN) annual revenue growth rate based on the revenue reported in the past 5 years is : 16.89%

Penumbra Inc's(PEN) is profitable as of its last reported annual financials.

The net profit margin for Penumbra Inc's(PEN) from its laster reported year is 1.17%

The return on equity (ROE) for Penumbra Inc's(PEN) from its last reported annual financials is : 1.20%

The return on assets (ROA) for Penumbra Inc's(PEN) from its last reported annual financials is : 4.84%

The return on invested capital (ROIC) for Penumbra Inc's(PEN) from its last reported annual financials is : 0.21%

The Debt to Equity ratio for Penumbra Inc's(PEN) from its last reported annual financials is : 0.00%

The dividend yield for Penumbra Inc's(PEN) from its laster reported year is 0.00%

Penumbra Inc's(PEN) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...